Newswise — SAN DIEGO, CA – Research presented Friday aims to
find an effective treatment for the two million Americans suffering
annually from moderate-to-severe heel pain. John J. Wilson, MD, MS,
AMSSM member, presented his research on plantar fasciitis entitled,
“Platelet-Rich Plasma for the Treatment of Chronic Plantar Fasciopathy
in Adults: A Randomized Controlled Clinical Trial” on Friday, April 19,
2013 at the American Medical Society for Sports Medicine’s 22nd Annual
Meeting in San Diego, Cal.
Dr. Wilson and his colleagues are
currently conducting a randomized controlled clinical trial
investigating platelet-rich plasma injection for the treatment of
chronic plantar fasciitis.
Plantar fasciitis is a musculoskeletal
disorder affecting the plantar fascia origin and is the most common
cause of heel pain in adults. Plantar fasciitis is an important cause of
pain and disability among athletes, but also prevalent in the general
population, especially sedentary individuals, with previous research
estimating two million Americans affected annually. Few studies have
assessed PRP as a treatment for plantar fasciitis, and no single study
has assessed the degree of correlation between the clinical,
biomechanical and ultrasound features of plantar fasciitis in response
to therapy.
The overall goal of this research is to find an
effective treatment for moderate-to-severe chronic (>6 month) plantar
fasciitis. This 32-week randomized controlled clinical trial compares
the effectiveness of PRP compared to corticosteroid injection for
refractory plantar fasciitis. The results from this high quality and
multi-disciplinary study will evaluate both clinical and radiographic
outcomes following two injection treatments for chronic plantar
fasciitis.
John J. Wilson, MD, MS, specializes in primary care
sports medicine. Dr. Wilson is a board certified assistant professor in
the departments of Orthopedics and Family Medicine and
fellowship-trained in sports medicine. He is a team physician for the
University of Wisconsin Athletic Department. In this role, he provides
medical coverage for the Badger men’s football and wrestling teams. Dr.
Wilson is a faculty member of the University of Wisconsin Stem Cell and
Regenerative Medicine Center and his current research includes
investigation of platelet-rich plasma (PRP) therapy for treatment of
chronic overuse injuries, and degenerative musculoskeletal conditions.
About the AMSSM:
The AMSSM is a multi-disciplinary organization of sports medicine
physicians whose members are dedicated to education, research, advocacy,
and the care of athletes of all ages. Founded in 1991, the AMSSM now
comprises more than 2,300 sports medicine physicians whose goal is to
provide a link between the rapidly expanding core of knowledge related
to sports medicine and its application to patients in a clinical
setting.
Source:
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου